(Date:11/25/2009)...le in French . , , Montreal, November 25, 20...he marketplace, thanks to a new partnership betwee... and Cognitive Sensing Inc. (CSI), a privately own...lor, which commercializes discoveries from the Uni... and CSI have announced the signature of a license...
(Date:11/25/2009)...ans at UT Southwestern Medical Center soon will be...eathing in patients with upper spinal-cord injurie...independently. , UT Southwestern University Hos...exas and one of 25 in the country currently equipp...gm Pacing System. , The device is designed to gi...
(Date:11/25/2009)...uccess for patients with liver lesions, researcher... News) -- Adding the drug cetuximab to neoadjuvant... of successful surgery in colorectal cancer patien...esearch suggests. , , Tumors spread to other p...h colorectal cancer. Most commonly, the cancer spr...
(Date:11/25/2009)...ndly ways to enjoy festive feasting , , ... the five-week holiday smorgasbord from Thanksgivi...the added pounds you,ll have to sweat off come Jan...ition experts, to enjoy holiday eating and make ..., It,s all about devising a strategy and thinking ...
(Date:11/25/2009)...llege teaches students to use natural treatments t... Burnaby, BC (Vocus) November 25, 2009 ...he standard, effective treatments in the fight aga...dicine to help them cope with the side effects of ...f cancer patients using acupuncture and herbal med...
Breaking Medicine News(10 mins):Health News:Univalor and Cognitive Sensing Inc. to commercialize 4 University of Montreal discoveries 2Health News:New device implanted by surgeons help paralyzed patients breathe easier 2Health News:Cetuximab Helps Treat Colorectal Cancer 2Health News:Holiday Eating Without the Guilt -- or the Pounds 2Health News:Holiday Eating Without the Guilt -- or the Pounds 3Health News:Holistic and Western Medicine Combined Can Fight Cancer 2(Date:11/25/2009).../PRNewswire/-- ChemoCentryx,Inc.,announcedtodayth...(theProspectiveRandomizedOralTherapyEvaluationinCr...ientswithmoderate-to-severeCrohn,sdiseasedemonstra...lityprofile.Thestudydemonstratedevidenceofclinical...a70-pointdecreaseintheCrohn,sDiseaseActivityIndex(...
(Date:11/24/2009)...wswire-FirstCall/--Vermillion,Inc.(VRML)(PinkSheet...ationandDisclosureStatementtoday,November24,2009,w...elaware.AhearingtoconsiderapprovaloftheDisclosureS...thehearingontheconfirmationofthePlanscheduledforJa...llclaimsinfull.ThePlanisexpected,ifapproved,toallo...
(Date:11/24/2009).../--Accumetrics,Inc.,aprivately-helddeveloperandmar...sy-to-usediagnosticsystemformeasuringanindividual,...174;andaspirin),announcedtodaythatTimothyI.Still,P...hiefFinancialOfficerofAccumetrics,willbepresenting...hCareConferencebeingheldinNewYorkCityonDecember1-2...
Breaking Medicine Technology:ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 2ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 3ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 4ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 5Vermillion Files Plan of Reorganization 2Vermillion Files Plan of Reorganization 3Accumetrics to Present at the 21st Annual Piper Jaffray Health Care Conference 2Seizures Not Epilepsy Itself May Raise Birth Risks 54172 1Seizures Not Epilepsy Itself May Raise Birth Risks 54172 2Oral Drug Ups Survival in Advanced Prostate Cancer Cases 54170 1Oral Drug Ups Survival in Advanced Prostate Cancer Cases 54170 2For Macho Men Doctor Visits Are Less Likely 54168 1For Macho Men Doctor Visits Are Less Likely 54168 2...A -- (MARKET WIRE) -- June 14,2007 -- Targeted Ge...ng data from the dose escalation arm of the ongoin... with inflammatory,arthritis. Philip J. Mease, M.D...ton School of Medicine, chief of rheumatology,clin...icing,physician with Seattle Rheumatology Associat...
...PRNewswire/ -- Prolexys,Pharmaceuticals and announ...of the selective small molecule anti-tumor agent,...,s,chemi-proteomics technology to understand the m...published in the June 14, 2007 issue,of the journa...l,voltage- dependent anion channels (VDACs) -- a n...
Other Medicine Technology:Targeted Genetics Reports Inflammatory Arthritis Clinical Data at,European Rheumatology Conference 2Targeted Genetics Reports Inflammatory Arthritis Clinical Data at,European Rheumatology Conference 3Targeted Genetics Reports Inflammatory Arthritis Clinical Data at,European Rheumatology Conference 4Targeted Genetics Reports Inflammatory Arthritis Clinical Data at,European Rheumatology Conference 5Targeted Genetics Reports Inflammatory Arthritis Clinical Data at,European Rheumatology Conference 6Prolexys Pharmaceuticals and Columbia University Researchers,Publish Study on Anti-Tumor Properties of a Selective Small,Molecule Anti-Tumor Agent With Novel Mechanism of Action 2Prolexys Pharmaceuticals and Columbia University Researchers,Publish Study on Anti-Tumor Properties of a Selective Small,Molecule Anti-Tumor Agent With Novel Mechanism of Action 3...tact lenses used for corneal refractive therapy, a... (myopia). The patient wears the lenses overnight ...ing the day, nearsightedness is corrected or great... lenses apply slight pressure to the center of the...
...e major challenges to operating your own Nuclear C...cedure includes:, NRC, state and other licensure...echnologist., New, dual head nuclear imaging camer...ure supplies, including pharmaceuticals., Radiatio...
... 330 ,Straight, ,Konan realized an ideal coa...een lenses for observation. This illumination shou...aryngology, ,Konan offers what no other conven...nction (1:3) and a clear image at every possible m...
...xperienced provider of mobile catheterization serv...bile laboratories serving hospital networks are mo...o another in a particular hospital network or geog...ped and operated by MedCath medical technicians an...
Medicine Products: